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Increasing infectious disease deaths, the emergence
of new infections, and bioterrorism have made surveillance
for infectious diseases a public health concern. Medical
examiners and coroners certify approximately 20% of all
deaths that occur within the United States and can be a key
source of information regarding infectious disease deaths.
We hypothesized that a computer-assisted search tool
(algorithm) could detect infectious disease deaths from a
medical examiner database, thereby reducing the time and
resources required to perform such surveillance manually.
We developed two algorithms, applied them to a medical
examiner database, and verified the cases identified
against the opinion of a panel of experts. The algorithms
detected deaths with infectious components with sensitivi-
ties from 67% to 94%, and predictive value positives rang-
ing from 8% to 49%. Algorithms can be useful for surveil-
lance in medical examiner offices that have limited
resources or for conducting surveillance across medical
examiner jurisdictions. 
I
nfectious disease deaths in the United States substantial-
ly declined during the first 8 decades of the 20th cen-
tury as a result of public health interventions. However, the
end of the century was marked by an increase in infectious
disease deaths primarily due to AIDS and pneumonia and
influenza (1,2). Increasing infectious disease deaths, the
emergence of new infections, and the real or perceived
threat of bioterrorist activities have made surveillance for
infectious diseases a public health need (3,4).
Infectious disease mortality trends have been described
by review of International Classification of Diseases
(ICD)–coded death certificate data (2). Although useful in
identifying trends, this process has certain limitations,
including the following: causes of death  are inaccurately
certified, are not autopsy verified, and are erroneously
coded; and ICD codes are not arranged to facilitate aggre-
gation of infectious disease mortality data or designed to
identify new infectious diseases (5). Medical examiners
and coroners are also a source of surveillance data for
infectious disease deaths. These investigators certify (i.e.
,enter information about the cause and manner of death on
death certificates) approximately 20% of all deaths that
occur within the United States (6). Medicolegal death
investigation systems are often biased towards the investi-
gation of violent or unnatural deaths. However, sudden
natural deaths, unexplained deaths, and deaths of public
health importance are also investigated by these agencies
(5,7–11).
Natural disease deaths investigated by medical examin-
ers and coroners are often caused by infectious processes
(12). Additionally, their investigation frequently includes a
complete autopsy. In recent years, medical examiners and
coroners have recognized outbreaks of hantavirus pul-
monary syndrome and invasive pneumococcal disease,
identified cases of human plague, and participated in the
investigation of West Nile encephalitis (13–16). In the
2001 outbreak of bioterrorism-related anthrax, all the
deaths were investigated by medical examiners (9–11,17).
Consequently, medical examiner/coroner databases can be
a key source of information about infectious diseases, both
in outbreak and nonoutbreak settings. 
In general, medical examiners are appointed physician
pathologists, usually with special training in performing
forensic autopsies and medicolegal death investigations;
coroners are usually elected officials, may not be physi-
cians, and rely on other medical personnel for death inves-
tigation and autopsy services (18). Medical examiner/coro-
ner systems are varied across the United States, ranging
from states with only medical examiners, states with only
coroners, and states with mixed medical examiner and
coroner systems (18). Overall, medical examiner systems
have larger jurisdictions and operate with more resources
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Francisco, California, October 25-28, 2001.than coroner systems. Medical examiner systems are more
likely to have electronic death investigation records.
Medical examiner and coroner databases contain pre-
dominantly noninfectious disease cases. Therefore, manu-
ally reviewing these databases to identify infectious dis-
ease cases is inefficient. Developing an automated system
that would identify a subset of cases that are likely infec-
tious, and then manually reviewing these cases to identify
infectious disease deaths, could reduce the resources that
would be necessary to perform infectious disease surveil-
lance. We hypothesized that a computer-assisted search
tool could quickly and efficiently detect infectious disease
deaths from a computerized medical examiner database,
thereby reducing the number of records that would need to
be manually reviewed to perform infectious disease sur-
veillance with medical examiner and coroner data. 
Methods
Case Identification
The New Mexico Office of the Medical Investigator
(OMI) is a statewide centralized medical examiner agency
based at the University of New Mexico School of
Medicine. OMI annually performs approximately 90% of
the autopsies in New Mexico (5). In 1995, New Mexico
had a midyear population of 1,682,417; that year, 12,545
deaths occurred in the state (Figure 1) (19,20). We
obtained a database of all deaths (Ntot = 4,722) in New
Mexico during 1995 that came under the jurisdiction of
OMI. From this database, autopsied deaths were identified
(naut = 1,429). A case-patient was defined as a person who
died in New Mexico during 1995 who had an infectious
disease identified at the time of death and who underwent
autopsy by OMI. An expert review panel (Infectious
Disease Death Review Team [IDDRT]) reviewed all
autopsy records and identified deaths that met the case def-
inition (ncd = 125). On the basis of the findings at autopsy,
we further categorized cases as an infectious cause of
death (ICOD) (ncod = 99) and infection incidental to death
(ninc = 26).
In addition to cause of death (disease or injury that ini-
tiates the fatal sequence of events), OMI cases are classi-
fied in terms of manner of death (circumstances, i.e., natu-
ral, accident, homicide, suicide, or undetermined). Deaths
that were considered natural or of undetermined manner
comprised 33% (471/1,429) of all OMI autopsies in 1995
and 85% (106/125) of the deaths identified as infectious
disease–related by the expert panel. The manner of death
was classified as an accident in 39% (561/1,429) of all
autopsied persons and in 13% (16/125) of deaths that were
identified as infectious disease–related by the expert panel.
Homicides and suicides accounted for 28% (395/1,429) of
OMI autopsies. 
Expert Review Panel
The IDDRT included specialists in infectious diseases,
forensic and clinical pathology, epidemiology, and infor-
mation technology and was in operation in New Mexico,
under the auspices of the OMI, from late 1994 to mid-1996
(5,12). One forensic pathologist member of the IDDRT
routinely reviewed all OMI autopsy records and identified
those deaths that were possibly infectious disease–related
for review by the expert panel.
Algorithm Development
We randomly divided ICOD cases into two groups: one
group (ndg = 49) was used for algorithm development (i.e.,
development group); the other group (ntg = 50) was used
for algorithm validity testing (i.e., test group). To develop
the algorithm, we reviewed the autopsy record for each
case in the development group. We developed two separate
algorithms based on two separate, but related, datasets
(Figure 2). These datasets are described below. 
The first algorithm (algorithm 1) was based on data
(i.e., truncated dataset) equivalent to information found on
the death certificate: demographic variables (e.g., age, sex,
and race); cause and manner of death; plus a brief descrip-
tion of the circumstances of death (i.e., a short narrative
reported by the death scene investigator). This dataset is
referred to as the “truncated” dataset. We used this dataset
because we wanted to evaluate the usefulness of death cer-
tificate information for this method because this informa-
tion may be readily available to persons performing sur-
veillance activities. We developed an algorithm based on
the development group of cases (ndg = 49). After the algo-
rithm was developed, we added the test group of cases (ntg
= 50) to the noninfectious cases (nani = 1,330) and applied
the algorithm to this database (nta = 1,380) to test the algo-
rithm’s ability to detect infectious disease deaths from the
truncated database.
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Figure 1. Flow chart for Infectious Disease Death Review Team
review and determination of infectious cause of death.The second algorithm (algorithm 2) was developed on
the basis of the full text of the pathologists’dictated autop-
sy records (i.e., full-text set), which included pathologic
observations, pathologic diagnoses, and causes of death.
This dataset contains much more detailed information than
the truncated dataset. It represents data that may be avail-
able from medical examiner offices, in addition to the
death certificate. Because we found a low predictive value
positive (PVP) and low specificity when algorithm 1 was
applied to the full-text dataset, we chose to develop algo-
rithm 2 in a different manner. We randomly selected
approximately half (n = 649) of the autopsy-categorized
deaths of noninfectious causes (nani = 1,380) to include in
the development of algorithm 2 to reduce the number of
false-positive cases the algorithm identified (i.e., cases
identified by the algorithm as infectious disease–related
but not actually infectious disease-related after expert
review). Therefore, the total number of deaths from all
manners used for algorithm 2 development was 698 (ndg2 =
698), and the total number of deaths used for testing algo-
rithm 2 was 732 (nta2 = 732). Algorithm development and
text searching were performed by using a commercially
available software package (AskSam 3.0 Professional,
Seaside Software, Inc., Perry, FL).
For developing both algorithms, we manually searched
and indexed potential keywords for identifying deaths
caused by infectious diseases. From this process, a list of
approximately 20 keywords and rules was compiled (i.e.,
algorithm; see Appendix). These keywords included entire
intact words, words put in a wildcard format (e.g., bacter*,
which would flag the words bacterial and bacteremia), and
words in a fuzzy search format (e.g., one letter in the word
could be wrong, and the word would still be flagged in the
record, thus decreasing misclassification caused by mis-
spelling and data entry errors). Rules included searching
for words in specific database fields (e.g., undetermined in
the cause of death field) and proximity rules (e.g., immune
within two words of deficiency). 
Algorithm Implementation and Analysis
The algorithms were applied to the remaining set of
records, which included all 1995 OMI autopsied cases
except for the development group set of cases (ntrc = 1,380
for the truncated dataset; nft = 732 for the full-text dataset).
We applied algorithm 1 to both the truncated and full-text
datasets and applied algorithm 2 to the full-text dataset to
determine whether an advantage existed in developing an
algorithm that used the data from full-text instead of data
that could be obtained from death certificates. We deter-
mined the sensitivity and PVP of the results by applying
the algorithm to this database. Thus, we compared the
cases identified from the database by using the algorithm
with cases identified by the expert review panel.
Results
Algorithm 1: Truncated Dataset
Algorithm 1 classified 131 (10%) of 1,380 (nta) autop-
sied deaths from the truncated dataset as infectious dis-
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Figure 2. Flow chart for algorithm 1 and 2 development and testing.
Table . Sensitivity and predictive value positive (PVP) of algorithm 1 and algorithm 2 applied to the truncated and full-text datasets, 
compared by manner of death and infection as cause of death 
Truncated dataset  Full-text dataset 
All causes of death 
Natural and undetermined 
causes of death  All causes of death 
Natural and undetermined 
causes of death 
  Sensitivity  PVP  Sensitivity  PVP  Sensitivity  PVP  Sensitivity  PVP 
ICOD and incidental 
infections
a                 
Algorithm 1  67%  
(51/76)  1 
39% 
(51/131) 1 
73%  
(46/63) 2 
49% 
(46/94) 2 
92%  
(70/76) 5 
8%  
(70/937) 5 
87%  
(55/63) 6 
17%  
(55/315) 6 
Algorithm 2  n/a  93%  
(71/76) 7 
20% 
(71/356) 7 
94%  
(58/62) 8 
30%  
(58/196) 8 
ICOD only
a                 
Algorithm 1  92% 
(46/50) 3 
49%  
(46/94) 3 
93%  
(42/45) 4 
45% 
(42/94)4 
88%  
(44/50) 9 
5%  
(44/937) 9 
89%  
(40/45)10 
13%  
(40/315)10 
Algorithm 2  n/a  90%  
(45/50) 11 
13% 
(45/356) 11 
91%  
(41/45) 12 
21%  
(41/196) 12 
aICOD, infectious cause of death. 
bNumber in bold in lower right corner of each cell corresponds to results of 2 x 2 table shown in Figure 3. ease–related (Table and Figure 3). Overall sensitivity for
identifying both ICOD and incidental infectious diseases
was 67% (51/76), and the overall PVP was 39% (51/131).
Implementation of the algorithm for surveillance for infec-
tious disease deaths would have resulted in a 91% decrease
(131 vs. 1,380) in the number of death records to review.
The algorithm identified ICOD cases with a sensitivity of
92% (46/50) and a PVP of 49% (46/94). 
Algorithm 1 identified deaths classified as natural or
undetermined and with an ICOD and incidental infections
from the truncated dataset with a sensitivity of 73%
(46/63) and a PVP of 49% (46/94). Implementation of the
algorithm for surveillance for infectious disease deaths
would have resulted in a 78% decrease (94 vs. 437) in the
number of death records to review. The algorithm identi-
fied deaths with both a natural or undetermined cause and
an ICOD with a sensitivity of 93% (42/45) and a PVP of
45% (42/94). 
Algorithm 1: Full-Text Dataset
When algorithm 1 was applied to the full-text dataset, it
classified 937 (68%) of 1,380 deaths as infectious dis-
ease–related. Sensitivity for accurately detecting all deaths
classified as natural or undetermined, for detecting deaths
caused by all infections, and for detecting those with an
ICOD only, ranged from 88% to 92% (Table). However,
PVPranged from 5% (for all causes of deaths, ICOD only)
to 17% (for those classified as natural or undetermined,
classified as ICOD, or identified as incidental infections).
Implementation of the algorithm for surveillance of infec-
tious disease deaths would have resulted in a 32% decrease
(937 vs. 1,380) in the number of death records to review
for all causes of death, and a 26% decrease (315 vs. 427)
for only natural and undetermined causes of death.
Algorithm 2: Full-Text Dataset
Algorithm 2 (developed on the basis of the full-text
dataset, which included panel-confirmed infectious disease
deaths and 50% of the noninfectious disease-related
deaths) was applied to the full-text dataset only. The sensi-
tivity of the algorithm to identify infectious disease–relat-
ed deaths ranged from 90% (all deaths; ICOD only) to
94% (natural or undetermined; ICOD or incidental infec-
tions). PVP ranged from 13% (all deaths; ICOD only) to
30% (natural or undetermined; ICOD or incidental infec-
tions). Implementation of the algorithm for surveillance of
infectious disease deaths would have reduced by 51% (356
vs. 732) the number of death records to review for deaths
from all causes and reduced by 24% the records to review
(196 vs. 257) of those deaths categorized as having natural
and undetermined causes.
Discussion
Asimple computer text search tool (i.e., algorithm) can
efficiently detect infectious disease deaths from a medical
examiner’s database, demonstrating that this technique can
be an essential tool in the surveillance for infectious dis-
eases of public health importance. Medical examiners are
a critical public health resource for fatal infectious disease
surveillance (5,12). Ideal surveillance at medical examiner
offices would include active case finding, as has been
implemented in a pilot program in New Mexico funded by
the Centers for Disease Control and Prevention (21).
Because infectious disease surveillance that uses medical
examiner data does not occur in a standardized manner, a
computer text search tool could be implemented by juris-
dictions that otherwise might not have the resources to per-
form these activities. Implementation of this technique
nationally would require large-scale development of elec-
tronic databases in medical examiner’s offices and subse-
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Figure 3. Two-by-two tables used to derive predictive value positive.quent incorporation of this surveillance tool into routine
activities. However, this method is also applicable to sur-
veillance for fatal infectious diseases and other conditions
at all medical facilities that collect text-based clinical data,
such as emergency departments, inpatient and outpatient
settings, and poison control centers.
The sensitivity of the algorithm varied depending on
whether it was applied to dictated autopsy records, includ-
ing all pathologic diagnoses, or to a truncated dataset con-
taining records equivalent to that found on a death certifi-
cate (i.e., basic demographic information and causes of
death). The expense of improved sensitivity is that more
records must be reviewed because of false-positive results.
Algorithm application on the truncated dataset achieved a
sensitivity similar to that achieved with the full-text
dataset, and with a higher PVP, for deaths in which an
infection is a cause of death rather than incidental to the
death. In addition, for the full-text dataset, sensitivity and
PVP were not substantially compromised by including in
the search, infections incidental to the cause of death.
Clearly, incidental infections are found among persons
who die from homicide, suicide, or accidents. Recognizing
incidental infections could be critical for surveillance sys-
tems designed to identify chronic infections such as tuber-
culosis and hepatitis C. Sensitivity was not compromised
by including deaths from all causes rather than deaths from
natural and undetermined causes. PVP was increased
somewhat by restricting the search to deaths classified as
natural and deaths classified as undetermined. Still, med-
ical examiner–based infectious disease surveillance could
effectively use complete data sets rather than data subsets.
This study was possible because of the findings from
the expert review of infectious disease deaths which could
be compared with data generated by the algorithm. This
panel reviewed records from approximately 90% of all
autopsies that occurred in New Mexico in 1 year and, of
these deaths, likely ascertained all OMI cases with an
infectious disease component. However, the implementa-
tion of such a review process using manually retrieved
cases might not be feasible in medical examiner jurisdic-
tions with limited resources and a large case volume. A
computerized algorithm could allow for surveillance in set-
tings where it otherwise might be impossible. Minimal
resources would be required to run the necessary software
and review results on a daily basis. Required software is
inexpensive, and running the algorithm would require min-
utes per day. Staff to interpret the results is the main
resource that would be required. These results demonstrat-
ed a substantial decrease in the number of records that
would need to be reviewed with algorithm implementation,
compared with those required by manual review alone.
In the future, search algorithms could be used in settings
where the records from several medicolegal jurisdictions
(e.g., a region consisting of more than one city, county, or
state) are combined. As outbreaks of infectious diseases,
whether naturally occurring or bioterrorism-related, might
span jurisdictional boundaries, computerized records could
be compiled from different areas and an algorithm applied
to seek patterns or clusters of deaths of one type during a
given period. To carry out such cross-regional surveillance,
standardized platforms of data collection that would allow
for data aggregation are required. Similar algorithms could
be used as permanent or temporary surveillance systems
designed to detect bioterrorism-related deaths or particular
outbreaks. In addition, these algorithms could be modified
to evaluate notifiable disease reporting in a jurisdiction.
Artificial intelligence techniques could be used to improve
algorithm accuracy. Artificial intelligence technology
could take algorithm development from rules derived from
human testing of specific terms and conditions (as per-
formed in this study), to algorithm development with com-
puter intelligence techniques that develop computer-
derived rules. Finally, algorithms could be developed that
would identify deaths caused by noninfectious conditions
of public health importance. 
This study documents a first step in using computer-
assisted text search tools to implement and improve infec-
tious disease surveillance with medical examiner data.
Research on computerized disease identification through
medical information is in the early stages (22).
Improvements in the algorithm, in algorithm development
techniques (such as improving search terms), and in apply-
ing algorithms in more diverse ways could enhance the
accuracy and usefulness of this method. Currently,
increased national and international attention is focused on
infectious disease surveillance. Novel surveillance strate-
gies that provide timely and detailed data will likely
become important adjuncts to traditional surveillance for
fatal infectious diseases. 
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